Jian Sun

Corporate Officer/Principal at Lianyuangang Chia Tai Tianqing Medicine Co., Ltd.

62 year

Health Technology

Profile

Jian Sun is currently the General Manager at Lianyuangang Chia Tai Tianqing Medicine Co., Ltd.
Prior to this, he was the President at Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

Jian Sun active positions

Companies	Position	Start
Lianyuangang Chia Tai Tianqing Medicine Co., Ltd.	Corporate Officer/Principal	2011-08-18

All active positions of Jian Sun

Former positions of Jian Sun

Companies	Position	End
Chia Tai Tianqing Pharmaceutical Group Co., Ltd. Chia Tai Tianqing Pharmaceutical Group Co., Ltd. Pharmaceuticals: MajorHealth Technology Part of Sino Biopharmaceutical Ltd., Chia Tai Tianqing Pharmaceutical Group Co., Ltd. is an innovative pharmaceutical group enterprise based in Lianyungang, China. Chia Tai Tianqing has six major product groups, including liver disease, anti-tumor, respiratory, infection, endocrine, and cardiovascular and cerebrovascular. The Chinese company invests heavily in innovative drug research and has high-level R & D platforms such as the national enterprise technology center. Chia Tai Tianqing is preparing for a number of products to enter the international market and actively undertakes corporate social responsibilities. The company was founded in 1969, and the CEO is Kang Xin Yu.	President	-

See the detail of Jian Sun's experience

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Jian Sun's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	2
Chia Tai Tianqing Pharmaceutical Group Co., Ltd. Chia Tai Tianqing Pharmaceutical Group Co., Ltd. Pharmaceuticals: MajorHealth Technology Part of Sino Biopharmaceutical Ltd., Chia Tai Tianqing Pharmaceutical Group Co., Ltd. is an innovative pharmaceutical group enterprise based in Lianyungang, China. Chia Tai Tianqing has six major product groups, including liver disease, anti-tumor, respiratory, infection, endocrine, and cardiovascular and cerebrovascular. The Chinese company invests heavily in innovative drug research and has high-level R & D platforms such as the national enterprise technology center. Chia Tai Tianqing is preparing for a number of products to enter the international market and actively undertakes corporate social responsibilities. The company was founded in 1969, and the CEO is Kang Xin Yu.	Health Technology
Lianyuangang Chia Tai Tianqing Medicine Co., Ltd.